On June 4, 2025, Ventyx Biosciences, Inc. held its Annual Meeting of Stockholders where key matters were voted on, including the re-election of two directors and approval of executive compensation, with about 70% shareholder participation. The appointment of Ernst & Young LLP as the independent auditor for 2025 was also ratified.